What blood tests are needed to diagnose von Willebrand disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Tests Required for von Willebrand Disease Diagnosis

The diagnosis of von Willebrand disease requires three essential initial blood tests: VWF antigen (VWF:Ag), VWF ristocetin cofactor activity (VWF:RCo), and factor VIII coagulant activity (FVIII). 1

Initial Laboratory Evaluation

First-line Tests

  • Complete blood count (CBC), prothrombin time (PT), and activated partial thromboplastin time (PTT) should be ordered if a bleeding disorder is suspected, though these do not specifically diagnose VWD 1
  • The three essential VWD-specific tests that should always be performed include:
    • VWF antigen (VWF:Ag) - measures the quantity of VWF protein 1
    • VWF ristocetin cofactor activity (VWF:RCo) - measures VWF function 1
    • Factor VIII coagulant activity (FVIII) - measures FVIII levels which are often affected in VWD 1

Interpretation of Initial Tests

  • VWF:RCo/VWF:Ag ratio below 0.5-0.7 suggests qualitative VWD (Type 2) rather than quantitative deficiency (Type 1) 1, 2
  • Normal ranges for these tests are typically 50-200 IU/dL for VWF:Ag, VWF:RCo, and FVIII 1
  • A definitive diagnosis of VWD is typically made when VWF:RCo is <30 IU/dL 1

Specialized Testing

Second-line Tests

  • VWF multimer analysis should be performed if initial testing reveals abnormal results or if clinical suspicion remains high despite normal initial tests 1
  • This test visualizes the distribution of VWF multimers and is crucial for determining VWD subtype, but is technically complex and not recommended for initial screening 1, 3

Additional Tests

  • Some laboratories may offer VWF collagen binding assay (VWF:CB) which can help distinguish between VWD subtypes, particularly Type 2M 4, 5
  • Newer assays like the INNOVANCE assay (VWF:Ac) may be used as alternatives to VWF:RCo in some laboratories 4, 6

Important Considerations for Testing

Sample Collection and Processing

  • Blood samples for VWF assays must be transported to the laboratory at room temperature 1
  • Plasma should be separated from blood cells promptly at room temperature 1
  • If testing will be delayed beyond 2 hours, samples must be frozen at or below -40°C 1

Factors Affecting Test Results

  • Patient factors that can elevate VWF and FVIII levels include stress, recent exercise, inflammatory illness, pregnancy, and oral contraceptives 7
  • The VWF:RCo assay has high coefficient of variation (10-30%), which may affect result interpretation 1
  • Repeat testing may be necessary due to variability in test results 1, 7

Diagnostic Pitfalls

  • Relying solely on a single test can lead to misdiagnosis - all three initial tests are required 7
  • Failure to consider ABO blood type when interpreting results (type O is associated with lower VWF levels) 1
  • Improper sample handling can significantly affect test results, potentially leading to false negatives or positives 1, 7
  • Patients with VWF:RCo between 30-50 IU/dL may still have VWD if there is supporting clinical or family evidence 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis of von Willebrand disease subtypes: implications for treatment.

Haemophilia : the official journal of the World Federation of Hemophilia, 2008

Research

Diagnosis or Exclusion of von Willebrand Disease Using Laboratory Testing.

Methods in molecular biology (Clifton, N.J.), 2017

Research

Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies.

Haemophilia : the official journal of the World Federation of Hemophilia, 2014

Guideline

Management of Von Willebrand Disease with Elevated Factor VIII Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.